SJS Investment Consulting’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Sell
657
-2
-0.3% -$685 0.03% 148
2026
Q1
$232K Sell
659
-100
-13% -$35.6K 0.03% 138
2025
Q4
$249K Hold
759
0.03% 119
2025
Q3
$214K Buy
759
+734
+2,936% +$213K 0.03% 126
2025
Q2
$7.06K Sell
25
-203
-89% -$57.5K ﹤0.01% 372
2025
Q1
$71.1K Buy
228
+190
+500% +$56.1K 0.01% 163
2024
Q4
$9.95K Sell
38
-6
-14% -$1.78K ﹤0.01% 351
2024
Q3
$14.2K Sell
44
-2
-4% -$654 ﹤0.01% 329
2024
Q2
$14.4K Sell
46
-7
-13% -$2.06K ﹤0.01% 302
2024
Q1
$15.1K Buy
53
+6
+13% +$1.76K ﹤0.01% 316
2023
Q4
$13.5K Hold
47
﹤0.01% 270
2023
Q3
$12.6K Buy
47
+15
+47% +$3.74K ﹤0.01% 267
2023
Q2
$7.11K Sell
32
-7
-18% -$1.62K ﹤0.01% 307
2023
Q1
$9.43K Sell
39
-12
-24% -$2.95K ﹤0.01% 298
2022
Q4
$13.4K Buy
51
+28
+122% +$7.51K ﹤0.01% 260
2022
Q3
$5K Buy
+23
New +$5.58K ﹤0.01% 329
2022
Q1
$12K Buy
47
+7
+18% +$1.61K ﹤0.01% 361
2021
Q4
$9K Buy
+40
New +$8.44K ﹤0.01% 381

Other funds holding AMGN

SJS Investment Consulting's AMGN Position: Q2 2026 in Review

SJS Investment Consulting reduced its Amgen (AMGN) stake by 0.3% in Q2 2026, selling an estimated $685 and leaving 657 shares worth $238K. The position accounts for 0.03% of the portfolio, ranked #148.

SJS Investment Consulting first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $249K in Q4 2025. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • SJS Investment Consulting held 657 shares of Amgen worth $238K as of Q2 2026.
  • SJS Investment Consulting sold 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.03% of SJS Investment Consulting's portfolio in Q2 2026, its #148 holding.
  • SJS Investment Consulting first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • SJS Investment Consulting's Amgen position peaked at $249K in Q4 2025.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.